What are the major opportunities in the Spikevax market? What are the strategies for the Spikevax market?

For detailed insights on the major opportunities and strategies in the Spikevax market, Read More

How does the Spikevax market relate to the overall economy and other similar markets?

For detailed insights on Spikevax's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Spikevax market growth? SWOT analysis of the Spikevax market.

For detailed insights on the key dynamics influencing the Spikevax market growth and SWOT analysis of the Spikevax industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Spikevax Global Market Report 2025

Name: Spikevax Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Clinical Indication (COVID-19), By Formulation (Spikevax Original, Spikevax Bivalent (Original Or Omicron), Spikevax XBB.1.5), By Age Group (Adults, Adolescents, Children), By Distribution Channel (Government Channels, Hospitals, Clinics)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Spikevax Market?

Spikevax is a vaccine designed to prevent coronavirus disease 2019 (COVID-19) in individuals aged 6 months and older. It was originally developed with an active ingredient called elasomeran, a messenger RNA (mRNA) molecule that carries genetic instructions for cells to produce a spike protein from the original SARS-CoV-2 strain, helping the immune system recognize and combat the virus.

The main clinical indication for spikevax is COVID-19. COVID-19 is a viral respiratory disease caused by SARS-CoV-2, resulting in symptoms such as fever, cough, and breathing issues. Spikevax is an mRNA-based vaccine, which works by instructing cells in the body to produce a protein similar to the spike protein found on the surface of the virus. This helps the immune system recognize and combat the covid virus if it enters the body. Various formulations are available for the spikevax such as spikevax original, spikevax bivalent (original or omicron), and spikevax XBB.1.5. It is distributed through various channels such as government channels, hospitals, and clinics and used by various age groups such as adults, adolescents, and children.

Spikevax Market Size and growth rate 2025 to 2029: Graph

What Is The Spikevax Market Size 2025 And Growth Rate?

The spikevax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rise in need for COVID-19 vaccines during the pandemic, rise in government funding, rapid regulatory approvals, rise in global vaccination campaigns, high efficacy against SARS-CoV-2 and its variants, and rise in partnerships for large-scale production and distribution.

What Is The Spikevax Market Growth Forecast?

The spikevax market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising booster shot campaigns, emergence of new SARS-CoV-2 variants, rising government contracts for pandemic preparedness, increasing vaccination rates in developing countries, expansion into pediatric and adolescent populations, and rising regulatory approvals for variant-specific formulations. Major trends in the forecast period include development of bivalent vaccines targeting multiple COVID-19 variants, advancements in storage system, enhanced mRNA technology for faster production, and integration of digital tools for vaccine tracking and monitoring.

Book your 30 minutes free consultation with our research experts

How Is The Spikevax Market Segmented?

The spikevax market covered in this report is segmented –

1) By Clinical Indication: COVID-19

2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5

3) By Age Group: Adults; Adolescents; Children

4) By Distribution Channel: Government Channels; Hospitals; Clinics

What Is Driving The Spikevax Market? Rising COVID-19 Cases Drive Growth In The Market

The rise in the prevalence of COVID cases is expected to propel the growth of the spikevax market going forward. COVID-19 is a disease caused by the SARS-CoV-2 virus, spreading through respiratory droplets and causing symptoms from mild fever to severe respiratory issues. Vaccines and hygiene practices help prevent its spread. COVID-19 cases are increasing due to factors such as new variants, reduced immunity, eased restrictions, seasonal indoor gatherings, and uneven vaccine coverage. Spikevax treat COVID-19 by teaching the immune system to recognize and combat the virus through an mRNA-induced spike protein, offering strong protection against severe disease and variants. For instance, in March 2023, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, as of March 2023, an estimated 1.9 million people in the UK (2.9% of the population) reported long COVID. Most (92%) had COVID-19 over 12 weeks earlier, with 69% experiencing symptoms for over a year and 41% for over two years. Therefore, the rise in the prevalence of COVID cases will drive the growth of the spikevax market forward.

What Is Driving The Spikevax Market? Rising Healthcare Investments Driving Growth In The Market

The rise in healthcare investments is expected to drive the growth of the spikevax market going forward. Healthcare investments refer to the total amount spent on healthcare services, including medical treatments, medications, and hospital care, within a specific period. Healthcare investments are rising due to factors such as an aging population, increasing healthcare needs, advancements in medical technology, and rising prices for services and medications. Healthcare investments drive Spikevax adoption by funding vaccine procurement, enhancing infrastructure, and improving delivery systems, thereby ensuring wider accessibility and supporting public health efforts. For instance, In May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rise in healthcare investments is going to drive the growth of the spikevax market forward.

Who Are The Major Players In The Global Spikevax Market?

Major companies operating in the spikevax market are Moderna Inc.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Spikevax Market? Moderna And Thermo Fisher Partner To Boost U.S. Production Of mRNA Medicines

In February 2022, Moderna Inc., a US-based biotechnology company, partnered with Thermo Fisher Scientific Inc. to boost U.S.-based production of Spikevax and other mRNA therapies. Thermo Fisher's extensive manufacturing services align with Moderna's objectives to scale production and advance its mRNA platform. Thermo Fisher Scientific Inc. is a US-based biotechnology company that specializes in the development and manufacture of life-changing therapies such as mRNA medicines.

Regional Analysis For The Global Spikevax Market

North America was the largest region in the spikevax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spikevax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spikevax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Spikevax Market?

The spikevax market consists of sales of COVID-19 vaccines, bivalent booster vaccines, syringes, and needles. Values in this market are ‘factory gate’ values, representing the value of vaccines sold directly by manufacturers, either to governments, healthcare organizations, or distribution networks. This includes revenues from related services but excludes resales further along the supply chain or integration into other healthcare products.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Spikevax Industry?

The spikevax market research report is one of a series of new reports from The Business Research Company that provides spikevax market statistics, including the spikevax industry's global market size, regional shares, competitors with a spikevax market share, detailed spikevax market segments, market trends and opportunities, and any further data you may need to thrive in the spikevax industry. This spikevax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Spikevax Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The spikevax market covered in this report is segmented – 1) By Clinical Indication: COVID-19 2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5 3) By Age Group: Adults; Adolescents; Children 4) By Distribution Channel: Government Channels; Hospitals; Clinics
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Moderna Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Spikevax Market Characteristics

3. Spikevax Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Spikevax Market Trends And Strategies

5. Spikevax Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Spikevax Growth Analysis And Strategic Analysis Framework

6.1. Global Spikevax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Spikevax Market Growth Rate Analysis

6.4. Global Spikevax Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Spikevax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Spikevax Total Addressable Market (TAM)

7. Global Spikevax Pricing Analysis & Forecasts

8. Spikevax Market Segmentation

8.1. Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

COVID-19

8.2. Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Spikevax Original

Spikevax Bivalent (Original Or Omicron)

Spikevax XBB.1.5

8.3. Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adults

Adolescents

Children

8.4. Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Government Channels

Hospitals

Clinics

9. Global Spikevax Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Spikevax Market Regional And Country Analysis

10.1. Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Spikevax Market

11.1. Asia-Pacific Spikevax Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Spikevax Market

12.1. China Spikevax Market Overview

12.2. China Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Spikevax Market

13.1. India Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Spikevax Market

14.1. Japan Spikevax Market Overview

14.2. Japan Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Spikevax Market

15.1. Australia Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Spikevax Market

16.1. South Korea Spikevax Market Overview

16.2. South Korea Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Spikevax Market

17.1. Western Europe Spikevax Market Overview

17.2. Western Europe Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Spikevax Market

18.1. UK Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Spikevax Market

19.1. Germany Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Spikevax Market

20.1. France Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Spikevax Market

21.1. Eastern Europe Spikevax Market Overview

21.2. Eastern Europe Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Spikevax Market

22.1. North America Spikevax Market Overview

22.2. North America Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Spikevax Market

23.1. USA Spikevax Market Overview

23.2. USA Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Spikevax Market

24.1. Canada Spikevax Market Overview

24.2. Canada Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Spikevax Market

25.1. South America Spikevax Market Overview

25.2. South America Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Spikevax Market

26.1. Middle East Spikevax Market Overview

26.2. Middle East Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Spikevax Market

27.1. Africa Spikevax Market Overview

27.2. Africa Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Spikevax Market Competitive Landscape And Company Profiles

28.1. Spikevax Market Competitive Landscape

28.2. Spikevax Market Company Profiles

28.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

29. Global Spikevax Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Spikevax Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Spikevax Market

32. Recent Developments In The Spikevax Market

33. Spikevax Market High Potential Countries, Segments and Strategies

33.1 Spikevax Market In 2029 - Countries Offering Most New Opportunities

33.2 Spikevax Market In 2029 - Segments Offering Most New Opportunities

33.3 Spikevax Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Moderna Inc. Financial Performance

Table 61: 0 Financial Performance

Table 62: 0 Financial Performance

Table 63: 0 Financial Performance

Table 64: 0 Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Moderna Inc. Financial Performance

Figure 61: 0 Financial Performance

Figure 62: 0 Financial Performance

Figure 63: 0 Financial Performance

Figure 64: 0 Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Immunity Boosting Food Products Market 2024 – By Product Source (Herbs And Species, Nuts And Seeds, Fruits And Vegetables, Dairy-Based Products, Prebiotics, Other Product Sources), By Form (Tablets, Capsules, Powder, Li...

COVID-19 Current Therapy Global Market Report 2025 – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others),...

COVID-19 Drug Associated APIs Global Market Report 2025 – By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class), By Synthesis Type (Synthetic, Biotech), By Business Mode (Captive API, ...

COVID-19 Detection Test Kits and Consumables Global Market Report 2025 – By Kits (Viral Load Testing Kits (qPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (Elisa), Viral Antigen Detection Test Ki...

Cybersecurity Services Market - By Security Type (Network Security, Endpoint Security, Application Security, Cloud security) By User Type (Large enterprises, Small And medium enterprises) And By Region, Opportunities And...

Next Generation Sequencing Market - By Product Type (Kits And Consumables, Software, Instruments), By Technology (Ion Semiconductor Sequencing, Sequencing by Synthesis, Single-molecule Real-time Sequencing, Other Sequenc...

Medication Adherence Market 2021 - By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal) And By Region, Opportunities ...

Frequently Asked Questions

What is the definition of the Spikevax market?

How will the Spikevax market drivers and restraints affect the market dynamics? What forces will shape the Spikevax industry going forward?

The Spikevax market major growth driver - Rising COVID-19 Cases Drive Growth In The Market. For further insights on the Spikevax market, request a sample here

What is the forecast market size or the forecast market value of the Spikevax market?

The Spikevax market size has grown strongly in recent years. The spikevax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rise in need for COVID-19 vaccines during the pandemic, rise in government funding, rapid regulatory approvals, rise in global vaccination campaigns, high efficacy against SARS-CoV-2 and its variants, and rise in partnerships for large-scale production and distribution. The spikevax market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising booster shot campaigns, emergence of new SARS-CoV-2 variants, rising government contracts for pandemic preparedness, increasing vaccination rates in developing countries, expansion into pediatric and adolescent populations, and rising regulatory approvals for variant-specific formulations. Major trends in the forecast period include development of bivalent vaccines targeting multiple COVID-19 variants, advancements in storage system, enhanced mRNA technology for faster production, and integration of digital tools for vaccine tracking and monitoring. For further insights on the Spikevax market, request a sample here

How is the Spikevax market segmented?

The spikevax market covered in this report is segmented –
1) By Clinical Indication: COVID-19
2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5
3) By Age Group: Adults; Adolescents; Children
4) By Distribution Channel: Government Channels; Hospitals; Clinics For further insights on the Spikevax market, request a sample here

Which region has the largest share of the Spikevax market? What are the other regions covered in the report?

Who are the major players in the Spikevax market?

Major companies operating in the spikevax market are Moderna Inc. . For further insights on the Spikevax market, request a sample here.

What are the key trends in the Spikevax market?

Major trends in the Spikevax market include . For further insights on the Spikevax market, request a sample here.